Inventor · disambiguated record
John Drewe
Also filed as: DREWE JOHN · DREWE JOHN A
30 granted patents·16 pending applications·884 citations·filing 1998–2016
97Inventor score
Files withCYTOVIA INC38MYRIAD GENETICS INC3Immune pharmaceuticals inc1MYRIAD PHARMACEUTICALS INC1SHIRE BIOCHEM INC1
Top patents by PatentIndex Score
46 records- 0197US6335429B1Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereofCYTOVIA INC·Filed 2000·Granted Jan 1, 2002·151 cites·18 claims
- 0295US7041685B2Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2002·Granted May 9, 2006·118 cites·12 claims
- 0394US6759207B2Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereofCYTOVIA INC·Filed 2001·Granted Jul 6, 2004·46 cites·38 claims
- 0493US7435750B2Method of using substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2005·Granted Oct 14, 2008·30 cites·12 claims
- 0593US6462041B1Gambogic acid, analogs and derivatives as activators of caspases and inducers of apoptosisCYTOVIA INC·Filed 2000·Granted Oct 8, 2002·44 cites·54 claims
- 0692US7618975B24-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereofMYRIAD PHARMACEUTICALS INC·Filed 2004·Granted Nov 17, 2009·61 cites·48 claims
- 0792US6716851B2Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators or caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2001·Granted Apr 6, 2004·43 cites·18 claims
- 0892US6342611B1Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereofCYTOVIA INC·Filed 1998·Granted Jan 29, 2002·89 cites·41 claims
- 0992US6184210B1Dipeptide apoptosis inhibitors and the use thereofCYTOVIA INC·Filed 1999·Granted Feb 6, 2001·76 cites·15 claims
- 1090US6153591ADipeptide caspase inhibitors and the use thereofCYTOVIA INC·Filed 1999·Granted Nov 28, 2000·85 cites·49 claims
- 1187US6596693B1Dipeptide apoptosis inhibitors and the thereofCYTOVIA INC·Filed 2000·Granted Jul 22, 2003·12 cites·10 claims
- 1286US6794397B2Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2001·Granted Sep 21, 2004·22 cites·25 claims
- 1384US6906203B1Substituted 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2000·Granted Jun 14, 2005·18 cites·27 claims
- 1481US7732468B23-aryl-6-aryl-[ 1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles and related compounds as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2007·Granted Jun 8, 2010·1 cites·4 claims
- 1581US7226927B2Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2003·Granted Jun 5, 2007·10 cites·20 claims
- 1681US6949516B2Dipeptide apoptosis inhibitors and the use thereofCYTOVIA INC·Filed 2003·Granted Sep 27, 2005·4 cites·14 claims
- 1780US7015328B2Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereofSHIRE BIOCHEM INC·Filed 2002·Granted Mar 21, 2006·9 cites·19 claims
- 1880US6716859B2Substituted N′-(Arylcarbonyl)-benzhydrazides, N′(Arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2002·Granted Apr 6, 2004·8 cites·7 claims
- 1979US6861419B2Substituted 1, 4-thiazepine and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2001·Granted Mar 1, 2005·12 cites·40 claims
- 2078US7270801B2Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for caspases and other enzymes and the use thereofCYTOVIA INC·Filed 2004·Granted Sep 18, 2007·3 cites·18 claims
- 2177US6747052B2Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2002·Granted Jun 8, 2004·5 cites·13 claims
- 2276US7235674B2Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2004·Granted Jun 26, 2007·6 cites·1 claims
- 2374US7176234B2Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosisCYTOVIA INC·Filed 2003·Granted Feb 13, 2007·8 cites·45 claims
- 2473US7507762B2Substituted 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2005·Granted Mar 24, 2009·1 cites·23 claims
- 2573US6794400B24-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2002·Granted Sep 21, 2004·7 cites·11 claims
- 2672US7135480B2Substituted 1-benzoyl-3-cyano-pyrrolo [1,2-a] quinolines and analogs as activators of caspases and inducers of apoptosisCYTOVIA INC·Filed 2003·Granted Nov 14, 2006·6 cites·21 claims
- 2765US6984718B2Fluorescence dyes and their applications for whole-cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereofCYTOVIA INC·Filed 2002·Granted Jan 10, 2006·9 cites·16 claims
- 2862US7074813B2Substituted N′-(arylcarbonyl)-benzhydrazides, N′-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2004·Granted Jul 11, 2006·0 cites·10 claims
- 2961US2008032974A1Compounds and therapeutical use thereofMYRIAD GENETICS INC·Filed 2007·Application pending·0 cites
- 3061US2008039479A1Compounds and therapeutical use thereofMYRIAD GENETICS INC·Filed 2007·Application pending·0 cites
- 3160US2007249601A1Compounds and therapeutical use thereofCYTOVIA INC·Filed 2007·Application pending·0 cites
- 3260US2007244113A1Compounds and therapeutical use thereofCYTOVIA INC·Filed 2007·Application pending·0 cites
- 3359US2007208044A1Compounds and therapeutical use thereofMYRIAD GENETICS INC·Filed 2007·Application pending·0 cites
- 3457US2008045514A13-Aryl-6-aryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2007·Application pending·0 cites
- 3555US2002128292A1Substituted indole-2-carboxylic acid benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereofFiled 2001·Application pending·0 cites
- 3655US2005192231A1Dipeptide apoptosis inhibitors and the use thereofFiled 2005·Application pending·0 cites
- 3755US2017050937A1Compounds and therapeutical use thereofImmune pharmaceuticals inc·Filed 2016·Application pending·0 cites
- 3853US2004235846A1Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2004·Application pending·0 cites
- 3951US7968595B2Substituted 4-aryl-chromene as activator of caspases and inducer of apoptosis and as antivascular agent and the use thereofCYTOVIA INC·Filed 2007·Granted Jun 28, 2011·0 cites·36 claims
- 4049US7256219B2Multifluoro-substituted chalcones and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2002·Granted Aug 14, 2007·0 cites·8 claims
- 4148US2007099941A1N-arylalkyl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2006·Application pending·0 cites
- 4246US2007244114A1Compounds and therapeutical use thereofCYTOVIA INC·Filed 2007·Application pending·0 cites
- 4343US2007253957A1Substituted N-Aryl-1H-Pyrazolo[3,4-B]Quinolin-4-Amines and Analogs as Activators of Caspases and Inducers of ApoptosisCYTOVIA INC·Filed 2005·Application pending·0 cites
- 4442US2003027229A1Methods of identifying potentially therapeutically selective and effective anti-cancer agents that are inducers of apoptosisCYTOVIA INC·Filed 2002·Application pending·0 cites
- 4542US2008096848A1Substituted N-Aryl-9-Oxo-9H-Fluorene-1-Carboxamides and Analogs as Activators of Caspases and Inducers of ApoptosisCYTOVIA INC·Filed 2005·Application pending·0 cites
- 4641US2005165053A1Substituted4-aryl-3-(3-aryl-1-oxo-2-propenyl)-2(1h)-quinolinones and analogs as activators of caspases and inducers of apoptosis and the use thereofCYTOVIA INC·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Drewe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →